WTO IP Exemptions Give Bangladesh, Indian Firms Competitive Leg-Up

The WTO Council's recent decision permitting least-developed country (LDC) members a 17-year exemption from implementing intellectual property (IP) provisions, such as patents, on medicines is expected to give Bangladesh's up-and-coming pharm industry valuable buffer time to catch up with and possibly take on some peers in the region.

More from Alimentary/Metabolic

More from Therapy Areas